Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease.

Bruno MK, Ravina B, Garraux G, Hallett M, Ptacek L, Singleton A, Johnson J, Singleton A, Hanson M, Considine E, Gwinn-Hardy K.

Mov Disord. 2004 Feb;19(2):228-30.

PMID:
14978684
2.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
3.

Progress in familial Parkinson's disease.

Mizuno Y, Hattori N, Yoshino H, Hatano Y, Satoh K, Tomiyama H, Li Y.

J Neural Transm Suppl. 2006;(70):191-204. Review.

PMID:
17017529
4.

Autosomal recessive parkinsonism.

Bonifati V.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S4-6. doi: 10.1016/S1353-8020(11)70004-9. Review.

PMID:
22166450
5.

Diagnostic considerations in juvenile parkinsonism.

Paviour DC, Surtees RA, Lees AJ.

Mov Disord. 2004 Feb;19(2):123-35. Review.

PMID:
14978667
6.

Autosomal recessive juvenile parkinsonism: a key to understanding nigral degeneration in sporadic Parkinson's disease.

Hattori N, Shimura H, Kubo S, Kitada T, Wang M, Asakawa S, Minashima S, Shimizu N, Suzuki T, Tanaka K, Mizuno Y.

Neuropathology. 2000 Sep;20 Suppl:S85-90. Review.

PMID:
11037196
7.

Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.

Hattori N, Shimura H, Kubo S, Wang M, Shimizu N, Tanaka K, Mizuno Y.

J Neural Transm Suppl. 2000;(60):101-16. Review.

PMID:
11205133
8.

Significance of the parkin gene and protein in understanding Parkinson's disease.

Fishman PS, Oyler GA.

Curr Neurol Neurosci Rep. 2002 Jul;2(4):296-302. Review.

PMID:
12044248
9.

Clinical inquiry. Which drugs work best for early Parkinson's disease?

Jain L, Benko R, Safranek S.

J Fam Pract. 2012 Feb;61(2):106-8. Review.

PMID:
22312616
10.

Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.

Fernandez HH, Odin P.

Curr Med Res Opin. 2011 May;27(5):907-19. doi: 10.1185/03007995.2011.560146. Epub 2011 Feb 25. Review.

PMID:
21351823
11.

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

Fahn S; Parkinson Study Group..

J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. Review.

PMID:
16222436
12.

[Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety].

Timofeeva AA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):145-51. Review. Russian.

PMID:
25629138
13.

Recessive Parkinson's disease.

Kubo S, Hattori N, Mizuno Y.

Mov Disord. 2006 Jul;21(7):885-93. Review.

PMID:
16615060
14.

Parkinson's disease. Update in diagnosis and symptom management.

Marjama-Lyons JM, Koller WC.

Geriatrics. 2001 Aug;56(8):24-5, 29-30, 33-5. Review.

PMID:
11505857
15.

Parkin-related disease clinically diagnosed as a pallido-pyramidal syndrome.

Wickremaratchi MM, Majounie E, Morris HR, Williams NM, Lewis H, Gill SS, Khan S, Heywood P, Hardy J, Wiles CM, Singleton AB, Quinn NP.

Mov Disord. 2009 Jan 15;24(1):138-40. doi: 10.1002/mds.22181. Review. No abstract available.

PMID:
18942080

Supplemental Content

Support Center